Kim SH - Search Results

1

Long-term outcomes of endoscopic submucosal dissection in gastric neoplastic lesions at a single institution in South Korea.

Jang JS, Choi SR, Qureshi W, Kim MC, Kim SJ, Jeung JS, Han SY, Noh MH, Lee JH, Lee SW, Baek YH, Kim SH, Choi PJ. Jang JS, et al. Among authors: kim sh, kim mc, kim sj. Scand J Gastroenterol. 2009;44(11):1315-22. doi: 10.3109/00365520903254304. Scand J Gastroenterol. 2009. PMID: 19891582

2

Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer.

Kwon HC, Kim SH, Oh SY, Lee S, Kwon KA, Lee JH, Choi HJ, Park KJ, Lee HS, Roh MS, Kim HJ. Kwon HC, et al. Among authors: kim hj, kim sh. Cancer Sci. 2010 Jun;101(6):1557-61. doi: 10.1111/j.1349-7006.2010.01553.x. Epub 2010 Mar 4. Cancer Sci. 2010. PMID: 20398057 Free PMC article.

3

Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.

Kwon KA, Kim SH, Oh SY, Lee S, Han JY, Kim KH, Goh RY, Choi HJ, Park KJ, Roh MS, Kim HJ, Kwon HC, Lee JH. Kwon KA, et al. Among authors: kim hj, kim sh, kim kh. BMC Cancer. 2010 May 14;10:203. doi: 10.1186/1471-2407-10-203. BMC Cancer. 2010. PMID: 20465852 Free PMC article.

4

Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy.

Kim KH, Kwon HC, Oh SY, Kim SH, Lee S, Kwon KA, Jang JS, Kim MC, Kim SJ, Kim HJ. Kim KH, et al. Among authors: kim hj, kim sh, kim mc, kim sj. Biomarkers. 2011 Feb;16(1):74-82. doi: 10.3109/1354750X.2010.533284. Epub 2010 Dec 6. Biomarkers. 2011. PMID: 21133646

5

Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer.

Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ, Park KJ, Roh MS, Kim SG, Kim HJ, Lee JH. Kwon HC, et al. Among authors: kim hj, kim sg, kim sh. Biomarkers. 2012 May;17(3):216-22. doi: 10.3109/1354750X.2012.656705. Epub 2012 Mar 17. Biomarkers. 2012. PMID: 22424597

6

Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.

Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim KH, Kim HJ. Lee S, et al. Among authors: kim hj, kim sh, kim mc, kim kh. BMC Cancer. 2013 Jul 22;13:350. doi: 10.1186/1471-2407-13-350. BMC Cancer. 2013. PMID: 23876227 Free PMC article.

7

Phase II study of gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial.

Oh SY, Kim WS, Lee DH, Kim SJ, Kim SH, Ryoo BY, Kang HJ, Choi YJ, Chung JS, Kim HJ, Suh C. Oh SY, et al. Among authors: kim hj, kim sh, kim sj, kim ws. Invest New Drugs. 2010 Apr;28(2):171-7. doi: 10.1007/s10637-009-9260-6. Epub 2009 May 7. Invest New Drugs. 2010. PMID: 19421710 Clinical Trial.

8

Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment.

Yi JH, Huh J, Kim HJ, Kim SH, Kim SH, Kim KH, Do YR, Mun YC, Kim H, Kim MK, Kim HJ, Kim T, Kim DD. Yi JH, et al. Among authors: kim dd, kim h, kim hj, kim sh, kim t, kim kh, kim mk. Ann Hematol. 2013 Apr;92(4):459-69. doi: 10.1007/s00277-012-1635-7. Epub 2012 Dec 23. Ann Hematol. 2013. PMID: 23262795

9

Prognostic significance of serum levels of vascular endothelial growth factor and insulin-like growth factor-1 in advanced gastric cancer patients treated with FOLFOX chemotherapy.

Oh SY, Kwon HC, Kim SH, Lee S, Lee JH, Graves CA, Camphausen K, Kim HJ. Oh SY, et al. Among authors: kim hj, kim sh. Chemotherapy. 2012;58(6):426-34. doi: 10.1159/000345918. Epub 2013 Jan 4. Chemotherapy. 2012. PMID: 23295255 Free PMC article. Clinical Trial.

10

The relationship of vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer.

Oh SY, Kwon HC, Kim SH, Lee S, Lee JH, Hwang JA, Hong SH, Graves CA, Camphausen K, Kim HJ, Lee YS. Oh SY, et al. Among authors: kim hj, kim sh. BMC Cancer. 2013 Feb 1;13:43. doi: 10.1186/1471-2407-13-43. BMC Cancer. 2013. PMID: 23374220 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,076 results

Search Page

Filters